Literature DB >> 24747132

Involvement of the AMPK-PTEN pathway in insulin resistance induced by high glucose in cultured rat podocytes.

Dorota Rogacka1, Agnieszka Piwkowska2, Irena Audzeyenka2, Stefan Angielski2, Maciej Jankowski3.   

Abstract

As part of the filtration barrier, podocytes play an important role in the development of diabetic nephropathy. Disturbances in insulin signaling accompanied by insulin resistance can lead to various intracellular events. We hypothesized that high glucose concentrations would lead to disturbances in interactions between AMPK and PTEN proteins in podocytes. Experiments were performed in primary rat podocytes cultured with normal (5.6mM) or high (30mM) glucose concentrations for 5d. Immunodetection methods were used to detect AMPK, PTEN, insulin receptor, and Akt proteins, and their phosphorylated forms. Insulin-stimulated changes in glucose uptake were used to detect insulin resistance. Isoforms of AMPK were detected by RT-PCR. AMPK and PTEN activities were modified by metformin, Compound C, siRNA for AMPK isoforms α1 and α2 and siRNA for PTEN, respectively. We found that impairment of insulin induction of glucose uptake into podocytes cultivated in the presence of high glucose concentrations for long periods of time is associated with increased PTEN levels in an AMPK-dependent manner.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMPK; Hyperglycemia; Metformin; PTEN; Podocytes

Mesh:

Substances:

Year:  2014        PMID: 24747132     DOI: 10.1016/j.biocel.2014.04.008

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  10 in total

1.  Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.

Authors:  Sebastian Langer; Reinhold Kreutz; Andreas Eisenreich
Journal:  J Nephrol       Date:  2016-01-05       Impact factor: 3.902

2.  AMPK controls the axonal regenerative ability of dorsal root ganglia sensory neurons after spinal cord injury.

Authors:  Guiping Kong; Luming Zhou; Elisabeth Serger; Ilaria Palmisano; Francesco De Virgiliis; Thomas H Hutson; Eilidh Mclachlan; Anja Freiwald; Paolo La Montanara; Kirill Shkura; Radhika Puttagunta; Simone Di Giovanni
Journal:  Nat Metab       Date:  2020-08-10

3.  Euglycemia in Diabetic Rats Leads to Reduced Liver Weight via Increased Autophagy and Apoptosis through Increased AMPK and Caspase-3 and Decreased mTOR Activities.

Authors:  Jun-Ho Lee; Soo-Bong Choi; Mingli Jin; Ju-Han Lee; Sang-Don Han; Hyemi Bae; Inja Lim; Yun-Hee Noh
Journal:  J Diabetes Res       Date:  2015-04-28       Impact factor: 4.011

4.  12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.

Authors:  Hong-Zhao Xu; Yan-Li Cheng; Wan-Ning Wang; Hao Wu; Yuan-Yuan Zhang; Chong-Sen Zang; Zhong-Gao Xu
Journal:  Int J Mol Sci       Date:  2016-05-06       Impact factor: 5.923

Review 5.  Glucose Transporters in Diabetic Kidney Disease-Friends or Foes?

Authors:  Anita A Wasik; Sanna Lehtonen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-09       Impact factor: 5.555

6.  Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.

Authors:  Zydrune Polianskyte-Prause; Tuomas A Tolvanen; Sonja Lindfors; Vincent Dumont; Mervi Van; Hong Wang; Surjya N Dash; Mika Berg; Jette-Britt Naams; Laura C Hautala; Harry Nisen; Tuomas Mirtti; Per-Henrik Groop; Kristiina Wähälä; Jukka Tienari; Sanna Lehtonen
Journal:  FASEB J       Date:  2018-10-15       Impact factor: 5.834

7.  Oridonin prevents insulin resistance-mediated cognitive disorder through PTEN/Akt pathway and autophagy in minimal hepatic encephalopathy.

Authors:  Fangfang Wen; Weishan Zhuge; Jian Wang; Xiaoai Lu; Ruimin You; Leping Liu; Qichuan Zhuge; Saidan Ding
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

Review 8.  Metformin Protects against Podocyte Injury in Diabetic Kidney Disease.

Authors:  Sanna Lehtonen
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-10

9.  Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.

Authors:  Anita Regmi; Geng Liu; Xueyu Zhong; Shengqing Hu; Rong Ma; Luoning Gou; Mohammad Ishraq Zafar; LuLu Chen
Journal:  Med Sci Monit       Date:  2019-03-05

Review 10.  Critical Role for AMPK in Metabolic Disease-Induced Chronic Kidney Disease.

Authors:  Florian Juszczak; Nathalie Caron; Anna V Mathew; Anne-Emilie Declèves
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.